Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Tularemia as a biological weapon: medical and public health management.
OBJECTIVE The Working Group on Civilian Biodefense has developed consensus-based recommendations for measures to be taken by medical and public health professionals if tularemia is used as a… Expand
Botulinum toxin as a biological weapon: medical and public health management.
People potentially exposed to botulinum toxin should be closely observed, and those with signs of botulism require prompt treatment with antitoxin and supportive care that may include assisted ventilation for weeks or months. Expand
Anthrax as a biological weapon, 2002: updated recommendations for management.
This revised consensus statement presents new information based on the analysis of the anthrax attacks of 2001, including developments in the investigation of the Anthrax Attacks of 2001; important symptoms, signs, and laboratory studies; new diagnostic clues that may help future recognition of this disease; updated antibiotic therapeutic considerations; and judgments about environmental surveillance and decontamination. Expand
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Specific recommendations are made regarding smallpox vaccination, therapy, postexposure isolation and infection control, hospital epidemiology and infection Control, home care, decontamination of the environment, and additional research needs. Expand
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
The final statement incorporates all relevant evidence obtained by the literature search in conjunction with final consensus recommendations supported by all working group members. Expand
Hemorrhagic fever viruses as biological weapons: medical and public health management.
Weapons disseminating a number of HFVs could cause an outbreak of an undifferentiated febrile illness 2 to 21 days later, associated with clinical manifestations that could include rash, hemorrhagic diathesis, and shock. Expand
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.
Specific consensus recommendations are made regarding the diagnosis of anthrax, indications for vaccination, therapy for those exposed, postexposure prophylaxis, decontamination of the environment, and additional research needs. Expand
Weapons of mass destruction events with contaminated casualties: effective planning for health care facilities.
This work discusses HCF planning for terrorist events that expose large numbers of people to contamination, and discusses the optimal choice of personal protective equipment, establishment of patient decontamination procedures, and potential environmental impacts on water treatment systems. Expand